Wein, Ferrante Comment on Telehealth Changes For Medicare Advantage Providers
April 27, 2020
Part B News
Of Counsel Emily Wein and Senior Counsel Thomas Ferrante were quoted in a Part B News article, “CMS lets MA providers do telehealth risk adjustment; tight documentation advised,” about a change in CMS policy allowing Medicare Advantage providers to do risk adjustment by telehealth during the coronavirus pandemic.
Wein said guidance on telehealth from Medicare administrative contractors (MAC) is helpful, but suggests that MA providers new to telehealth go a step further and walk through their reasoning in notes. “Maybe in the initial stages, providers should take extra efforts to show professional judgment was exercised in using telehealth, not just assert ‘the MAC said I could,’” she said.
Ferrante said providers should not offer a provisional diagnosis for risk adjustment purposes contingent on the patient coming in when the current emergency is lifted. “I don’t know if the subsequent visit would be reimbursable,” he said. “If you think the provider had enough under the current emergency guidance, what would be the justification for bringing the patient in again?”
(Subscription required.)
Wein said guidance on telehealth from Medicare administrative contractors (MAC) is helpful, but suggests that MA providers new to telehealth go a step further and walk through their reasoning in notes. “Maybe in the initial stages, providers should take extra efforts to show professional judgment was exercised in using telehealth, not just assert ‘the MAC said I could,’” she said.
Ferrante said providers should not offer a provisional diagnosis for risk adjustment purposes contingent on the patient coming in when the current emergency is lifted. “I don’t know if the subsequent visit would be reimbursable,” he said. “If you think the provider had enough under the current emergency guidance, what would be the justification for bringing the patient in again?”
(Subscription required.)
People
Related News
September 18, 2026
In the News
Patrick Daugherty Authors Article on Navigating Proposed SEC Crypto Asset Regulations
Foley & Lardner LLP partner Patrick Daugherty authored the Columbia Law School’s Blue Sky Blog article, “How to Advise Token Developers in Light of Proposed SEC Regulation Crypto Assets.”
September 17, 2026
In the News
Foley Featured in Law.com for Guiding Kontoor Brands in Sale of Lee®
Foley & Lardner LLP partner Bryan Schultz is featured for leading the Foley deal team which advised Kontoor Brands in the sale of its Lee® business in Law.com's “How the Deal Got Done” series.
September 15, 2026
In the News
David Rosen Shares Insights on FDA Efforts to Accelerate Human Clinical Trials
Foley & Lardner LLP partner David Rosen shared insights in the recent Law360 article, “FDA Seeks Applications For Project To Speed Up Human Trials,” on the FDA's pilot program pairing pharmaceutical companies with research institutions to accelerate human clinical trials.